149 related articles for article (PubMed ID: 15588465)
21. Updated meta-analysis of recombinant follicle-stimulating hormone (FSH) versus urinary FSH for ovarian stimulation in assisted reproduction.
Daya S
Fertil Steril; 2002 Apr; 77(4):711-4. PubMed ID: 11937121
[TBL] [Abstract][Full Text] [Related]
22. Myo-inositol administration positively effects ovulation induction and intrauterine insemination in patients with polycystic ovary syndrome: a prospective, controlled, randomized trial.
Emekçi Özay Ö; Özay AC; Çağlıyan E; Okyay RE; Gülekli B
Gynecol Endocrinol; 2017 Jul; 33(7):524-528. PubMed ID: 28277112
[TBL] [Abstract][Full Text] [Related]
23. Clomiphene citrate co-treatment with low dose urinary FSH versus urinary FSH for clomiphene resistant PCOS: randomized controlled trial.
Ghanem ME; Elboghdady LA; Hassan M; Helal AS; Gibreel A; Houssen M; Shaker ME; Bahlol I; Mesbah Y
J Assist Reprod Genet; 2013 Nov; 30(11):1477-85. PubMed ID: 24014214
[TBL] [Abstract][Full Text] [Related]
24. The impact of a gonadotropin-releasing hormone antagonist on gonadotropin ovulation induction cycles in women with polycystic ovary syndrome: a prospective randomized study.
Stadtmauer LA; Sarhan A; Duran EH; Beydoun H; Bocca S; Pultz B; Oehninger S
Fertil Steril; 2011 Jan; 95(1):216-20. PubMed ID: 20594551
[TBL] [Abstract][Full Text] [Related]
25. Recombinant FSH increases live birth rates as compared to clomiphene citrate in intrauterine insemination cycles in couples with subfertility: a prospective randomized study.
Erdem M; Abay S; Erdem A; Firat Mutlu M; Nas E; Mutlu I; Oktem M
Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():33-7. PubMed ID: 25855325
[TBL] [Abstract][Full Text] [Related]
26. Aromatase inhibition reduces the dose of gonadotropin required for controlled ovarian hyperstimulation.
Mitwally MF; Casper RF
J Soc Gynecol Investig; 2004 Sep; 11(6):406-15. PubMed ID: 15350255
[TBL] [Abstract][Full Text] [Related]
27. Ovulation induction using low-dose step-up rFSH in Vietnamese women with polycystic ovary syndrome.
Lan VT; Norman RJ; Nhu GH; Tuan PH; Tuong HM
Reprod Biomed Online; 2009 Apr; 18(4):516-21. PubMed ID: 19400993
[TBL] [Abstract][Full Text] [Related]
28. Long-term follow-up of laparoscopic electrocautery of the ovaries versus ovulation induction with recombinant FSH in clomiphene citrate-resistant women with polycystic ovary syndrome: an economic evaluation.
Nahuis MJ; Oude Lohuis E; Kose N; Bayram N; Hompes P; Oosterhuis GJ; Kaaijk EM; Cohlen BJ; Bossuyt PP; van der Veen F; Mol BW; van Wely M
Hum Reprod; 2012 Dec; 27(12):3577-82. PubMed ID: 23001778
[TBL] [Abstract][Full Text] [Related]
29. Sequential low-dose step-up and step-down protocols with recombinant follicle-stimulating hormone in polycystic ovary syndrome: prospective comparison with step-down protocol.
Casadei L; Puca F; Emidi E; Manicuti C; Madrigale A; Piccione E
Arch Gynecol Obstet; 2012 Nov; 286(5):1291-7. PubMed ID: 22729136
[TBL] [Abstract][Full Text] [Related]
30. Recombinant versus urinary follicle-stimulating hormone in the low-dose regimen in anovulatory patients with polycystic ovary syndrome: a safer and more effective treatment.
Fulghesu AM; Apa R; Belosi C; Ciampelli M; Selvaggi L; Cucinelli F; Caruso A; Mancuso S; Lanzone A
Horm Res; 2001; 55(5):224-8. PubMed ID: 11740143
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the efficacy of the aromatase inhibitor letrozole and clomiphene citrate as adjuvants to recombinant follicle-stimulating hormone in controlled ovarian hyperstimulation: a prospective, randomized, blinded clinical trial.
Barroso G; Menocal G; Felix H; Rojas-Ruiz JC; Arslan M; Oehninger S
Fertil Steril; 2006 Nov; 86(5):1428-31. PubMed ID: 16978619
[TBL] [Abstract][Full Text] [Related]
32. Recombinant vs. urinary follicle-stimulating hormone in couples undergoing intrauterine insemination. A randomized study.
Isaza V; Requena A; García-Velasco JA; Remohí J; Pellicer A; Simón C
J Reprod Med; 2003 Feb; 48(2):112-8. PubMed ID: 12621795
[TBL] [Abstract][Full Text] [Related]
33. Cost-effectiveness of aromatase inhibitor co-treatment for controlled ovarian stimulation.
Bedaiwy MA; Forman R; Mousa NA; Al Inany HG; Casper RF
Hum Reprod; 2006 Nov; 21(11):2838-44. PubMed ID: 16877370
[TBL] [Abstract][Full Text] [Related]
34. Advantages of recombinant follicle-stimulating hormone over human menopausal gonadotropin for ovarian stimulation in intrauterine insemination: a randomized clinical trial in unexplained infertility.
Rashidi M; Aaleyasin A; Aghahosseini M; Loloi S; Kokab A; Najmi Z
Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(2):244-7. PubMed ID: 23541417
[TBL] [Abstract][Full Text] [Related]
35. [Clinical effects of recombinant versus urinary gonadotropins in ovulation induction].
Streda R; Koryntová D; Mardesic T; Sobotka V; Sobotková J
Ceska Gynekol; 2011 Apr; 76(2):108-13. PubMed ID: 21649993
[TBL] [Abstract][Full Text] [Related]
36. Ovulation induction with low-dose follicle-stimulating hormone in women with the polycystic ovary syndrome.
Dale O; Tanbo T; Lunde O; Abyholm T
Acta Obstet Gynecol Scand; 1993 Jan; 72(1):43-6. PubMed ID: 8382432
[TBL] [Abstract][Full Text] [Related]
37. Induction of ovulation in women undergoing assisted reproductive techniques: recombinant human FSH (follitropin alpha) versus highly purified urinary FSH (urofollitropin HP).
Lenton E; Soltan A; Hewitt J; Thomson A; Davies W; Ashraf N; Sharma V; Jenner L; Ledger W; McVeigh E
Hum Reprod; 2000 May; 15(5):1021-7. PubMed ID: 10783345
[TBL] [Abstract][Full Text] [Related]
38. The cost-effectiveness of IVF in the UK: a comparison of three gonadotrophin treatments.
Sykes D; Out HJ; Palmer SJ; van Loon J
Hum Reprod; 2001 Dec; 16(12):2557-62. PubMed ID: 11726574
[TBL] [Abstract][Full Text] [Related]
39. [Effectiveness, safety and cost of urinary follicle stimulating hormone in controlled ovarian stimulation in China: multi-center retrospective cohort study of 102 061 in vitro fertilization cycles].
Zhu YM; Gao Y; Nai DH; Hu LL; Jin L; Zhong Y; Wu Z; Hao GM; Wu QF; Guan YC; Jiang H; Zhang CL; Liu ML; Wang XH; Teng XM; Duan JL; Li LR; Zhang Y; Ye H
Zhonghua Fu Chan Ke Za Zhi; 2022 Jul; 57(7):510-518. PubMed ID: 35902785
[No Abstract] [Full Text] [Related]
40. Highly purified FSH is as efficacious as recombinant FSH for ovulation induction in women with WHO Group II anovulatory infertility: a randomized controlled non-inferiority trial.
Balen A; Platteau P; Andersen AN; Devroey P; Helmgaard L; Arce JC;
Hum Reprod; 2007 Jul; 22(7):1816-23. PubMed ID: 17449511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
